0000080424FalseFalse00000804242025-07-292025-07-290000080424us-gaap:CommonStockMember2025-07-292025-07-290000080424exch:XNYS2025-07-292025-07-290000080424pg:A0.110NotesDue2026Domain2025-07-292025-07-290000080424pg:A3.25EURNotesDue2026Domain2025-07-292025-07-290000080424pg:A4.875EURNotesDueMay2027Domain2025-07-292025-07-290000080424pg:A1.200NotesDue2028Domain2025-07-292025-07-290000080424pg:A3.150EURNotesDue2028Domain2025-07-292025-07-290000080424pg:A1.250NotesDue2029Domain2025-07-292025-07-290000080424pg:A1.800NotesDue2029Domain2025-07-292025-07-290000080424pg:A6.250GBPNotesDueJanuary2030Domain2025-07-292025-07-290000080424pg:A0.350NotesDue2030Domain2025-07-292025-07-290000080424pg:A0.230NotesDue2031Domain2025-07-292025-07-290000080424pg:A3.250EURNotesDue2031Domain2025-07-292025-07-290000080424pg:A5.250GBPNotesDueJanuary2033Domain2025-07-292025-07-290000080424pg:A3.200EURNotesDue2034Domain2025-07-292025-07-290000080424pg:A1.875NotesDue2038Domain2025-07-292025-07-290000080424pg:A0.900NotesDue2041Domain2025-07-292025-07-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): 7/29/2025
___________________________________
The Procter & Gamble Company
(Exact name of registrant as specified in its charter)
___________________________________
| | | | | | | | |
Ohio (State or other jurisdiction of incorporation or organization) | 001-00434 (Commission File Number) | 31-0411980 (I.R.S. Employer Identification Number) |
One Procter & Gamble Plaza Cincinnati, Ohio 45202 |
(Address of principal executive offices and zip code) |
(513) 983-1100 |
(Registrant's telephone number, including area code) |
___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| | | | | |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| | | | | | | | |
Securities registered pursuant to Section 12(b) of the Act: |
Title of each class | Trading Symbol | Name of each exchange on which registered |
Common Stock without Par Value | PG | NYSE |
0.110% Notes due 2026 | PG26D | NYSE |
3.25% EUR Notes due 2026 | PG26F | NYSE |
4.875% EUR Notes due May 2027 | PG27A | NYSE |
1.200% Notes due 2028 | PG28 | NYSE |
3.150% EUR Notes due 2028 | PG28B | NYSE |
1.250% Notes due 2029 | PG29B | NYSE |
1.800% Notes due 2029 | PG29A | NYSE |
6.250% GBP Notes due January 2030 | PG30 | NYSE |
0.350% Notes due 2030 | PG30C | NYSE |
0.230% Notes due 2031 | PG31A | NYSE |
3.250% EUR Notes due 2031 | PG31B | NYSE |
5.250% GBP Notes due January 2033 | PG33 | NYSE |
3.200% EUR Notes due 2034 | PG34C | NYSE |
1.875% Notes due 2038 | PG38 | NYSE |
0.900% Notes due 2041 | PG41 | NYSE |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 7.01 - Regulation FD Disclosure
On July 29, 2025, The Procter & Gamble Company (the "Company") issued a press release announcing its fourth quarter and fiscal year 2025 results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website.
This 8-K is being furnished pursuant to Item 7.01, "Regulation FD Disclosure."
Item 9.01 - Financial Statements and Exhibits
(d): The following exhibits are being filed herewith:
| | | | | | | | |
Exhibit No. | | Description |
99.1 | | Informational Slides Provided by The Procter & Gamble Company dated July 29, 2025. |
104 | | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 29th day of July, 2025.
| | | | | |
THE PROCTER & GAMBLE COMPANY |
| |
By: | /s/ Sandra T. Lane |
Name: | Sandra T. Lane |
Title: | Assistant Secretary |
INDEX TO EXHIBIT(S)
99.1 - Informational Slides Provided by The Procter & Gamble Company dated July 29, 2025.